The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...

AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Researchers have identified a promising new strategy to treat autoimmune diseases by targeting a specific molecular interaction within immune cells.

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.

For many women with lupus, midlife isn't just another chapter-it's a recalibration. Careers are often at their most demanding. Aging parents may need support. Children, if you have them, are ...

Lupus is a systemic autoimmune disease that creates inflammation in many parts of your body. It can also affect your skin, causing a rash or other skin changes. Most people with lupus will develop ...

A common gut bacterium may be implicated in lupus kidney disease, and could potentially alter the diagnosis and treatment of ...

Please provide your email address to receive an email when new articles are posted on . Identifying negative social determinants of health can improve outcomes in lupus. Physician education is needed ...